Equity Overview
Price & Market Data
Price: $0.27
Daily Change: -$0.055 / 20.37%
Daily Range: $0.26 - $0.325
Market Cap: $683,494
Daily Volume: 3,893
Performance Metrics
1 Week: -10.34%
1 Month: -13.33%
3 Months: -10.34%
6 Months: -99.70%
1 Year: -99.97%
YTD: -99.85%
Company Details
Employees: 39
Sector: Health technology
Industry: Biotechnology
Country:
Details
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States. Its product pipeline comprises OmnImmune (TCB002), an allogeneic unmodified gamma-delta T cell therapy product which is in phase 2/3 clinical trial for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections, as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.